MAP2K7 and cancer: One of the earliest studied aspects of the induction and reactivation of dormant cancer cells was the extracellular matrix (ECM), and it was shown that the association of the urokinase plasminogen activator receptor (uPAR) with α5β1 integrin activates the MEK/ERK pathway and plays an inhibitory role in cancer dormancy [83].